TRIB Competitors & Alternatives
Compare Trinity Biotech plc with similar stocks in the same industry
In Vitro & In Vivo Diagnostic Substances
TRIB
Main Stock$0.78
Tradestie Score
49
Market Cap
$3.80M
Revenue Growth
0.2%
Analyst Upside
+283.8%
Top Competitors
19 stocks in In Vitro & In Vivo Diagnostic Substances| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IDXX
Idexx Laboratories Inc
|
$632.56
|
$49.61B | 48.8 | 50 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$66.00
|
$3.51B | 27.6 | 57 | Compare |
|
QDEL
QuidelOrtho Corporation Common Stock
|
$27.98
|
$2.12B | - | 54 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.05
|
$2.01B | - | 56 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$25.17
|
$1.68B | - | 48 | Compare |
|
NNNN
Anbio Biotechnology Class A Ordinary Shares
|
$27.22
|
$1.53B | 411.0 | 41 | Compare |
|
NEOG
Neogen Corp
|
$10.27
|
$1.26B | - | 55 | Compare |
|
MYGN
Myriad Genetics Inc
|
$5.34
|
$719.23M | - | 53 | Compare |
|
TKNO
Alpha Teknova, Inc. Common Stock
|
$2.44
|
$340.89M | - | 45 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$4.19
|
$158.43M | - | 50 | Compare |
More TRIB Analysis
Data updated: Feb 04, 2026 | Industry: In Vitro & In Vivo Diagnostic Substances (SIC 2835)
19 stocks in this industry